According to FutureWise analysis the market for Plasmapheresis Market in 2023 is US$ 1.4 billion, and is expected to reach US$ 2.52 billion by 2031 at a CAGR of 7.60%.
Increased incidences of autoimmune diseases, growing insistence for plasma source from biopharma companies, improving healthcare infrastructure and awareness programs in both developed and developing nations, favourable scenario for reimbursements on plasmapheresis processes and other technological advancements are some of the key driving factors responsible for the plasmapheresis market growth.
Plasmapheresis or plasma exchange is a process that involves the separation and removal of plasma from the blood for eliminating an element of a disease present in the plasma. The RBCs, platelets and WBCs are returned to the patient with an additional fluid recommended by the physician. The process of plasmapheresis removes over 15 percent of plasma from the total blood volume of a patient therefore no additional plasma is required to be removed. Plasmapheresis generally involves plasma collection for manufacturing products like albumin, IVIG, factor concentrates and laboratory reagents and for transfusion. Furthermore, the increased incidences of autoimmune disorders have exponentially increased the demand for this procedure across the world.
Autoimmune diseases like celiac diseases, type 1 diabetes, rheumatoid arthritis, lupus and temporal arteritis have increased the plasmapheresis market demand. As per the report published by the CDC, over 9% of the total population of the United States suffer from diabetes and over 30 million people are diagnosed with diabetes across the world. Healthcare companies are consistently improving in the development of plasmapheresis instruments like apheresis machines to provide enhancements in these instruments to conduct this process across the world. Owing to these factors the market is predicted to proliferate during the forecasted timeframe. Moreover, the plasma is required to treat different diseases like anaemia, blood loss, stomach disease, cancer which has surged the insistence for blood donations. Such factors have significantly contributed to the growth of the market.